litlas
Log inCreate account

Gerd Geißlinger

Active 1990–2026

Also published as
Gerd Geisslinger
193
Papers
20,109
Citations
87
h-index
185
i10-index

Citations

Citations per year for Gerd Geißlinger1990: 3 citations1991: 2 citations1992: 11 citations1993: 3 citations1994: 7 citations1995: 5 citations1996: 13 citations1997: 9 citations1998: 25 citations1999: 20 citations2000: 46 citations2001: 66 citations2002: 65 citations2003: 109 citations2004: 126 citations2005: 133 citations2006: 179 citations2007: 166 citations2008: 172 citations2009: 209 citations2010: 184 citations2011: 195 citations2012: 172 citations2013: 182 citations2014: 157 citations2015: 143 citations2016: 113 citations2017: 109 citations2018: 104 citations2019: 522 citations2020: 562 citations2021: 565 citations2022: 540 citations2023: 389 citations2024: 582 citations2025: 250 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,888 citing papers, 24.8% of this breakdownGermany: 863 citing papers, 11.3% of this breakdownChina: 842 citing papers, 11% of this breakdownUnited Kingdom: 460 citing papers, 6% of this breakdownItaly: 311 citing papers, 4.1% of this breakdownCanada: 258 citing papers, 3.4% of this breakdownAustralia: 203 citing papers, 2.7% of this breakdownFrance: 197 citing papers, 2.6% of this breakdownSpain: 177 citing papers, 2.3% of this breakdownSwitzerland: 173 citing papers, 2.3% of this breakdownNetherlands: 156 citing papers, 2% of this breakdownJapan: 148 citing papers, 1.9% of this breakdown
0%24.8%Other 25.6%

Institutions

Fields

  • Medicine50.5%
  • Biochemistry, Genetics and Molecular Biology25.6%
  • Neuroscience8%
  • Immunology and Microbiology4.2%
  • Pharmacology, Toxicology and Pharmaceutics3.4%
  • Computer Science2.1%
  • Other6.2%

Topics

  • Pain Mechanisms and Treatments5.8%
  • Sphingolipid Metabolism and Signaling3.4%
  • Inflammatory mediators and NSAID effects3.2%
  • Pain Management and Opioid Use2%
  • Neuropeptides and Animal Physiology1.8%
  • Immune cells in cancer1.6%
  • Other82.2%

Coauthors

All papers

Open in search
  1. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2

    Authors: Susanne Krasemann, Undine Haferkamp, Susanne Pfefferle, Marcel S. Woo, Fabian Heinrich, Michaela Schweizer, Antje Appelt‐Menzel, Alevtina Cubukova, Janica Barenberg, Jennifer Leu, Kristin Hartmann, Edda Thies, Jessica Lisa Littau, Diego Sepúlveda‐Falla, Liang Zhang, Kathy Ton, Yan Liang, Jakob Matschke, Franz Ricklefs, Thomas Sauvigny, Jan Sperhake, Antonia Fitzek, Anna Gerhartl, Andreas Brachner, Nina Geiger, Eva‐Maria König, Jochen Bodem, Sören Franzenburg, André Franke, Stefan Moese, Franz-Josef Müller, Gerd Geißlinger, Carsten Claussen, Aimo Kannt, Andrea Zaliani, Philip Gribbon, Benjamin Ondruschka, Winfried Neuhaus, Manuel A. Friese, Markus Glatzel, Ole Pleß - Stem Cell Reports 2022 cited by 239

  2. Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?

    Authors: Nils Helge Schebb, Hartmut Kühn, Astrid S. Kahnt, Katharina M. Rund, Valerie B. O’Donnell, Nicolas Flamand, Marc Peters‐Golden, Per‐Johan Jakobsson, Karsten H. Weylandt, Nadine Rohwer, Robert C. Murphy, Gerd Geißlinger, Garret A. FitzGerald, Julien Hanson, Cláes Dahlgren, Mohamad Wessam Alnouri, Stefan Offermanns, Dieter Steinhilber - Frontiers in Pharmacology 2022 cited by 184

  3. Autophagy activation, lipotoxicity and lysosomal membrane permeabilization synergize to promote pimozide- and loperamide-induced glioma cell death

    Authors: Nina Meyer, Lisa Henkel, Benedikt Linder, Svenja Zielke, Georg Tascher, Sandra Trautmann, Gerd Geißlinger, Christian Münch, Simone Fulda, Irmgard Tegeder, Donat Kögel - Autophagy 2021 cited by 108

  4. Chain length-specific properties of ceramides

    Authors: Sabine Grösch, Susanne Schiffmann, Gerd Geißlinger - Progress in Lipid Research 2011 cited by 472

  5. Proton-Sensing GPCRs in Health and Disease

    Authors: Marco Sisignano, Michael J. M. Fischer, Gerd Geißlinger - Cells 2021 cited by 99

  6. THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro

    Authors: Hiromi Shiratori, Carmen Feinweber, Sonja Luckhardt, Bona Linke, Eduard Resch, Gerd Geißlinger, Andreas Weigert, Michael J. Parnham - Molecular Immunology 2017 cited by 192

  7. Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorder

    Authors: Nathalie Brunkhorst-Kanaan, Katharina Klatt‐Schreiner, Juliane Hackel, Katrin Schröter, Sandra Trautmann, Lisa Hahnefeld, Sabine Wicker, Andreas Reif, Dominique Thomas, Gerd Geißlinger, Sarah Kittel‐Schneider, Irmgard Tegeder - Metabolism 2019 cited by 133

  8. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain

    Authors: Marco Sisignano, Ralf Baron, Klaus Scholich, Gerd Geißlinger - Nature Reviews Neurology 2014 cited by 350

  9. Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen

    Authors: Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geißlinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Goßen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, Andrea Zaliani - ACS Pharmacology & Translational Science 2021 cited by 159

  10. Ziconotide for treatment of severe chronic pain

    Authors: Achim Schmidtko, Jörn Lötsch, Rainer Freynhagen, Gerd Geißlinger - The Lancet 2010 cited by 351

  11. Pre-analytical sample handling standardization for reliable measurement of metabolites and lipids in LC-MS-based clinical research

    Authors: Ashley Sens, Samuel Rischke, Lisa Hahnefeld, Erika Dorochow, S.M.G. Schäfer, Dominique Thomas, Michaela Köhm, Gerd Geißlinger, Frank Behrens, Robert Gurke - Journal of Mass Spectrometry and Advances in the Clinical Lab 2023 cited by 71

  12. SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain

    Authors: Saskia Wedel, Praveen Mathoor, Oliver Rauh, Tim Heymann, Cosmin I. Ciotu, Dominik C. Fuhrmann, Michael J. M. Fischer, Andreas Weigert, Natasja de Bruin, Felix Hausch, Gerd Geißlinger, Marco Sisignano - Journal of Neuroinflammation 2022 cited by 45

  13. Ceramides as Novel Disease Biomarkers

    Authors: Jennifer Kurz, Michael J. Parnham, Gerd Geißlinger, Susanne Schiffmann - Trends in Molecular Medicine 2018 cited by 196

  14. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence

    Authors: Irmgard Tegeder, Michael Costigan, Robert S. Griffin, Andrea Abele, Inna Belfer, Helmut Schmidt, Corina Ehnert, Jemiel Nejim, Claudiu Marian, Joachim Scholz, Tianxia Wu, Andrew Allchorne, Luda Diatchenko, Alexander M. Binshtok, David Goldman, Jan Adolph, Swetha Sama, Steven J. Atlas, William A. Carlezon, Aram Parsegian, Jörn Lötsch, Roger B. Fillingim, William Maixner, Gerd Geißlinger, Mitchell B. Max, Clifford J. Woolf - Nature Medicine 2006 cited by 546

  15. Selective Antagonism of Opioid-Induced Ventilatory Depression by an Ampakine Molecule in Humans Without Loss of Opioid Analgesia

    Authors: B. Oertel, Lisa Felden, P.V. Tran, Mark Bradshaw, Martin S. Angst, Harald Schmidt, Steve A. Johnson, John J. Greer, Gerd Geißlinger, Mark A. Varney, Jörn Lötsch - Clinical Pharmacology & Therapeutics 2009 cited by 132

  16. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

    Authors: Constanze Schneider, Thomas Oellerich, Hanna‐Mari Baldauf, Sarah-Marie Schwarz, Dominique Thomas, Robert Flick, Hanibal Bohnenberger, Lars Kaderali, Lena Stegmann, Anjali Cremer, Margarethe Martin, Julian J.K. Lohmeyer, Martin Michaelis, Veit Hornung, Christoph Schliemann, Wolfgang E. Berdel, Wolfgang Hartmann, Eva Wardelmann, Federico Comoglio, Martin‐Leo Hansmann, Alexander F. Yakunin, Gerd Geißlinger, Philipp Ströbel, Nerea Ferreirós, Hubert Serve, Oliver T. Keppler, Jindřich Činátl - Nature Medicine 2016 cited by 185

  17. Capturing adenylyl cyclases as potential drug targets

    Authors: Sandra Pierre, Thomas Eschenhagen, Gerd Geißlinger, Klaus Scholich - Nature Reviews Drug Discovery 2009 cited by 223

  18. Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth

    Authors: Daniela Hartmann, Jessica Lucks, Sina Fuchs, Susanne Schiffmann, Yannick Schreiber, Nerea Ferreirós, Jennifer Merkens, Rolf Marschalek, Gerd Geißlinger, Sabine Grösch - The International Journal of Biochemistry & Cell Biology 2012 cited by 216

  19. Pharmacokinetics of Non-Intravenous Formulations of Fentanyl

    Authors: Jörn Lötsch, Carmen Walter, Michael J. Parnham, B. Oertel, Gerd Geißlinger - Clinical Pharmacokinetics 2012 cited by 138

  20. Activated Platelets Induce an Anti-Inflammatory Response of Monocytes/Macrophages through Cross-Regulation of PGE2and Cytokines

    Authors: Bona Linke, Yannick Schreiber, Bettina Picard‐Willems, Patrick Slattery, Rolf M. Nüsing, Sebastian Harder, Gerd Geißlinger, Klaus Scholich - Mediators of Inflammation 2017 cited by 104

  21. Oxidized linoleic acid metabolites maintain mechanical and thermal hypersensitivity during sub-chronic inflammatory pain

    Authors: Saskia Wedel, Tabea Osthues, Béla Zimmer, Carlo Angioni, Gerd Geißlinger, Marco Sisignano - Biochemical Pharmacology 2022 cited by 33

  22. Slack Channels Expressed in Sensory Neurons Control Neuropathic Pain in Mice

    Authors: Ruirui Lu, Anne E. Bausch, Wiebke Kallenborn-Gerhardt, Carsten Stoetzer, Natasja Debruin, Peter Ruth, Gerd Geißlinger, Andreas Leffler, Robert Łukowski, Achim Schmidtko - Journal of Neuroscience 2015 cited by 87

  23. A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis

    Authors: Jurema Schmidt, M Rotter, Tim Weiser, Sandra K. Wittmann, Lilia Weizel, Astrid Kaiser, Jan Heering, Tamara Goebel, Carlo Angioni, Mario Wurglics, Alexander Paulke, Gerd Geißlinger, Astrid S. Kahnt, Dieter Steinhilber, Ewgenij Proschak, Daniel Merk - Journal of Medicinal Chemistry 2017 cited by 82

  24. Promoter Activation in Δhfq Mutants as an Efficient Tool for Specialized Metabolite Production Enabling Direct Bioactivity Testing

    Authors: Edna Bode, Antje K. Heinrich, Merle Hirschmann, Desalegne Abebew, Yan‐Ni Shi, Tien Duy Vo, Frank Wesche, Yi‐Ming Shi, Peter Grün, Svenja Simonyi, Nadine Keller, Yvonne Engel, Sebastian L. Wenski, Reuel Bennet, Sophie Beyer, Iris Bischoff, Anthony Buaya, Sophie Brandt, İbrahim Çakmak, Harun Çimen, Simone Eckstein, Denia Frank, Robert Fürst, Martin Gand, Gerd Geißlinger, Selçuk Hazır, Marina Henke, Ralf Heermann, Virginie Lecaudey, Wilhelm Schäfer, Susanne Schiffmann, Anja Schüffler, Rebecca Schwenk, Marisa Škaljac, Eckhard Thines, Marco Thines, Thomas Ulshöfer, Andreas Vilcinskas, Thomas A. Wichelhaus, Helge B. Bode - Angewandte Chemie 2019 cited by 73